IRADIMED CORPORATION Achieves Recognition in TIME's Growth Leaders List
IRADIMED CORPORATION (NASDAQ: IRMD), a trailblazer in creating innovative magnetic resonance imaging (MRI)-compatible medical devices, has earned a notable spot on TIME's distinguished list of America's Growth Leaders for 2026. This achievement highlights the company’s significant advancements, marking its presence among the leading U.S. companies that showcase exceptional growth as evaluated by TIME and Statista.
The Ranking Overview
The evaluation process scrutinized thousands of public companies, assessing three crucial metrics: Revenue Growth, Financial Health, and Stock Performance. Each of these aspects carried equal weight in a comprehensive scoring model, ultimately spotlighting the top 501 companies that exemplified remarkable business growth. Iradimed impressively secured the 79th position on this prestigious list.
“We are truly honored to be recognized among TIME's America's Growth Leaders for 2026,” shared Roger Susi, the President and Chief Executive Officer of Iradimed. “This accolade underscores our team's unwavering dedication to innovation and operational excellence while providing consistent returns to our shareholders. Achieving 17 consecutive quarters of record revenue, combined with our robust financial stability and strong stock performance, showcases the effectiveness of our strategic approach within the MRI-compatible medical device sector. Our heartfelt thanks go out to our employees for their dedication and to our shareholders for their ongoing support.”
Comprehensive Evaluation Methodology
TIME and Statista employed a meticulous, data-driven framework to assess U.S.-based public companies, focusing on three evenly weighted categories:
1. Revenue Growth
This dimension emphasized the compound annual growth rate (CAGR) spanning from 2021 to 2024, setting a minimum revenue threshold to ensure the quality of ranked companies.
2. Financial Stability
This analysis included profitability assessments alongside traditional metrics like the Piotroski F-Score and Altman Z-Score, offering a comprehensive view of financial health.
3. Stock Performance
Companies were evaluated based on multiple performance indicators, including average annual growth rate, recent returns, comparison to overall market performance, and volatility over the preceding five years.
The data gathered was integrated into a scoring system with a maximum of 100 points, culminating in the selection of the 501 companies that have earned the title of America's Growth Leaders for 2026.
About IRADIMED CORPORATION
IRADIMED CORPORATION is at the forefront of developing inventive MRI-compatible medical devices. The company is deeply involved in the design, manufacturing, marketing, and distribution of these essential devices, accessories, and disposables tailored for MRI environments.
Notably, IRADIMED is renowned as the sole provider of a non-magnetic intravenous (IV) infusion pump system specifically engineered for safety during MRI procedures. The innovative infusion system significantly mitigates the risks and issues commonly encountered during MRIs. Traditional infusion pumps possess magnetic and electronic parts that can interfere with MRI systems' radio frequencies, rendering them hazardous. Thankfully, the MRidium® MRI-compatible IV infusion pump features a non-magnetic ultrasonic motor and uniquely designed non-ferrous elements to ensure safe delivery of anesthesia and other IV fluids throughout various MRI procedures.
Moreover, the IRADIMED 3880 MRI-compatible patient vital signs monitoring system was crafted with non-magnetic components, allowing for secure and precise monitoring of patients' vital signs during MRI sessions. Designed to operate reliably in magnetic fields of up to 30,000 gauss, this system guarantees outstanding functionality in the MRI scanner room. The compact and lightweight design enables easy transportation of the device alongside the patient, thereby enhancing safety through consistent monitoring and minimizing the duration critically ill patients are away from their care units.
Features of the Iradimed 3880 include wireless ECG with advanced filtering, accurate wireless SpO2 using Masimo® algorithms, non-magnetic respiratory CO2 monitoring, invasive and non-invasive blood pressure measurements, and patient temperature tracking. An optional advanced multi-gas anesthetic agent unit offers continuous Minimum Alveolar Concentration readings. This system combines usability with effective communication of patient vital signs to clinical staff.
For further details regarding our innovative solutions, please visit our official website at www.iradimed.com.
Contact Information
Media Contact:
Jack Glenn
IRADIMED CORPORATION
(407) 677-8022
For investor inquiries, please reach out via email at InvestorRelations@iradimed.com.
Frequently Asked Questions
What is IRADIMED CORPORATION's primary focus?
IRADIMED CORPORATION primarily focuses on developing MRI-compatible medical devices, ensuring safety and efficiency during medical procedures.
How did IRADIMED rank on TIME's list?
IRADIMED secured the 79th position on TIME's list of America's Growth Leaders for 2026.
What factors contributed to their ranking?
The ranking was based on key growth factors such as revenue growth, financial stability, and stock performance.
What is the MRidium® infusion pump?
The MRidium® is a non-magnetic IV infusion pump designed for safe use during MRI procedures, mitigating risks associated with traditional pumps.
How can I learn more about their products?
You can learn more about IRADIMED's products by visiting their official website at www.iradimed.com.
